Are you a Business Owner?
Set up your Private Seller Account and create your listing todayGet Started Here
We're professional business services company. We provide following services:
- Mergers and Acquisitions deals management (selling and buying businesses and assets)
- Business Projects Management (including online, Tech, Real Estate, new lines of business)
We do business across GCC, CIS, EU and North America. With us you will find the best and safest way how to realize your business project or finalize a deal. Our clients trust us, join to our community.
Below you will find one of our businesses for sale.
An investor required in the heparin production plant. The plant doesn’t have competitors in local market. Planned return (ROI) is 60%. Payback period is 3 years. Planning to be No. 1 in Russia and CIS.
Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. As a medication it is used as an anticoagulant (blood thinner). Specifically it is also used in the treatment of heart attacks and unstable angina. Other uses include inside test tubes and kidney dialysis machines.
The global heparin market size was estimated at USD 6.49 billion in 2018 and is projected to expand at a CAGR of 1.6%. At the moment, in Russia there is no full-cycle production of heparin. All heparin used in Russian pharmaceutical industry is imported from abroad.
- Location: Tomsk, Russia
- Plant area: 1500 m2
- Land area: 10,000 m2
- Number of employees: 40 people
- Already invested: $ 6 million
Investments required: $ 10 Million:
Planned indicators (2022):
- Turnover : $ 25 million
- EBIDTA: $ 15 million
- Profitability: 60%
- Return on investment for the investor (ROI): 3 years
This is your chance to invest in a business that has big chance to become the leading company in the Russia in heparin production.
Real Property Included
If you own a business and are considering selling, visit our Sell a Business section. Limited Trial available.Sell Your Business